TNF and juvenile idiopathic arthritis: A real-life study that compared retention of anti-TNFα agents in patients with juvenile idiopathic arthritis (< 16 years) and patients with adult-onset disease found that adults more frequently discontinued treatment owing to lack of efficacy and AEs (severe infection and neoplasms), although both groups had similar retention rates at 10 years30.